Ivabradine for treatment of heart failure (2019)
Bocchi, Edimar Alcides 
; Salemi, Vera Maria Cury
Source: Expert opinion on drug safety. Unidade: FM
Subjects: DOENÇA DE CHAGAS, INSUFICIÊNCIA CARDÍACA, PROGNÓSTICO, FIBRILAÇÃO ATRIAL, BETA-BLOQUEADORES, TAQUICARDIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCCHI, Edimar Alcides e SALEMI, Vera Maria Cury. Ivabradine for treatment of heart failure. Expert opinion on drug safety, v. 18, n. 5, p. 393-402, 2019Tradução . . Disponível em: https://doi.org/10.1080/14740338.2019.1612873. Acesso em: 09 ago. 2024.APA
Bocchi, E. A., & Salemi, V. M. C. (2019). Ivabradine for treatment of heart failure. Expert opinion on drug safety, 18( 5), 393-402. doi:10.1080/14740338.2019.1612873NLM
Bocchi EA, Salemi VMC. Ivabradine for treatment of heart failure [Internet]. Expert opinion on drug safety. 2019 ; 18( 5): 393-402.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1080/14740338.2019.1612873Vancouver
Bocchi EA, Salemi VMC. Ivabradine for treatment of heart failure [Internet]. Expert opinion on drug safety. 2019 ; 18( 5): 393-402.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1080/14740338.2019.1612873
